semaglutide description Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is an increasingly popular medication for improving glycemic control and promoting weight loss in patients with type 2 diabetes or obesity. Although gastrointestinal symptoms What Is Semaglutide? A Medical

An email from July 16, 2025 shows DSS General Counsel Matthew S

Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells

The medication works by enhancing insulin secretion in a glucose-dependent manner, suppressing inappropriate glucagon secretion, slowing gastric emptying, and reducing appetite

But and this is important that doesnt automatically mean no more sleep apnea or no more PAP. It means better than placebo in carefully selected trial populations, measured using sleep study metrics

Understanding what goes wrong and why motivates the precision this guide demands